From: Biomarkers characterization of circulating tumour cells in breast cancer patients
CTC+, number (percentage) | CTC-, number (percentage) | Pvalue (χ2) | |
---|---|---|---|
Age, years | |||
≤ 50 | 14 (41.2) | 20 (58.8) | |
> 50 | 32 (50) | 32 (50) | NS |
Histology | |||
Ductal | 40 (47) | 45 (53) | |
Others | 6 (46.2) | 7 (53.8) | NS |
Clinical tumor size | |||
≤ 2 cm | 25 (54.3) | 21 (45.7) | |
> 2-5 cm | 15 (39.5) | 23 (60.5) | |
> 5 cm | 6 (42.9) | 8 (57.1) | NS |
Clinical nodal status | |||
cN0 | 28 (47.5) | 31 (52.5) | |
cN+ | 11 (34.4) | 21 (65.6) | NS |
Unknown | 4 (57.1) | 3 (42.9) | |
Grade | |||
I | 8 (38.1) | 13 (61.9) | |
II | 15 (44.1) | 19 (55.9) | |
III | 20 (55.5) | 16 (44.5) | |
Unknown | 3 (42.9) | 4 (57.1) | NS |
Hormonal status | |||
HR+ | 35 (46.7) | 40 (53.3) | |
HR- | 11 (47.8) | 12 (52.2) | NS |
HER2 status | |||
HER2+ | 3 (21.4) | 11 (78.6) | |
HER2- | 43 (51.2) | 41 (48.8) | 0.046 |
p53 status | |||
p53+ | 26 (51) | 25 (49) | |
p53- | 7 (50) | 7 (50) | |
Unknown | 13 (39.4) | 20 (60.6) | NS |
Ki-67 percentage | |||
≤ 14% | 20 (52.6) | 18 (47.4) | |
> 14% | 26 (43.3) | 34 (56.7) | NS |